CTNNA1 and gastric cancer: Screening for CDH1 and CTNNA1 mutation (alongside other genes associated with increased risk of gastric cancer in the case of unexplained gastric cancer in some families) should be performed in individuals who fulfil criteria for genetic testing, followed by a thorough evaluation and interdisciplinary approach to establish the best therapeutic approach (endoscopic surveillance versus prophylactic gastrectomy).